Antisense Therapeutics Limited (AU:PER) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics Limited has announced a proposed issuance of 135,231,746 ordinary fully paid securities, aimed at boosting its capital. This strategic move is set to take place on October 24, 2024, potentially increasing the company’s market presence and attracting investors. Such placements are often seen as opportunities for growth and expansion within the financial markets.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.